#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Skin angiosarcoma Gastroenteropancreatic neuroendocrine tumour disease Short stature homeobox gene mutation Epilepsy Fibrodysplasia ossificans progressiva Cutaneous T-cell lymphoma refractory Sickle cell disease Congenital nephrogenic diabetes insipidus Neuromyelitis optica spectrum disorder Haemolytic uraemic syndrome Congenital growth hormone deficiency Round cell liposarcoma Ocular myasthenia Cardiac arrest Porphyria non-acute More trials…
Learn about Rare Diseases

Atypical haemolytic uraemic syndrome – Trials in Disease Mantle cell lymphoma stage IV – Life with Disease Wiskott-Aldrich syndrome – Life with Disease Ewing’s sarcoma recurrent – Treatment Metachromatic leukodystrophy – Basic Information Adrenocortical carcinoma Glycogen storage disease type V – Life with Disease Acquired haemophilia – Treatment Marfan’s syndrome – Basic Information Angelman’s syndrome – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Abbv-668 Fostemsavir Pristinamycin Iron Mdna11 Olaparib Other Immunosuppressants C1 Esterase Inhibitor (Human) Hhalpc Cls12311 Loperamide Hydrochloride Mk-1942 PARECOXIB Iti-1284 Idecabtagene Vicleucel HSP-CAR19M Mebufotenin Iodine (123I) Iobenguane Apadamtase Alfa Ivospemin More therapies…

Learn about Your Condition

Brain neoplasm malignant Vomiting Testicular germ cell tumour Adrenocortical carcinoma Malignant peritoneal neoplasm HER2 protein overexpression Corneal graft rejection Large cell lung cancer stage 0 Biliary neoplasm Hypereosinophilic syndrome Neoplasm Oesophageal carcinoma Antithrombin III deficiency PIK3CA-activated mutation Erythema More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Neurogenic bladder

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

Recruiting

4 1 1
Investigated Drugs:
- Vibegron
+3
Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

Recruiting

3 1 1
Investigated Diseases:
- Neurogenic bladder
Investigated Drugs:
- E.coli Polysaccharide
Study on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity

Not recruiting

3 1 1
Investigated Diseases:
- Neurogenic bladder
- Hypertonic bladder
Investigated Drugs:
- Mirabegron

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Neurogenic bladder

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

Study on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies